SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study. Edelstein GE, Boucau J, Uddin R, Marino C, et al. Ann Intern Med 2023 Nov 14. doi: 10.7326/M23-1756.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Edelstein GE, Boucau J, Uddin R, Marino C, et al. SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study. Ann Intern Med 2023 Nov 14. doi: 10.7326/M23-1756.
PMID: 37956428